Supplement safety · public sources

Omega-3 fatty acids and fish oil safety

FDA adverse-event reports, NIH guidance on interactions, and registered trials.

  1. Research Tracker
  2. Supplement safety
  3. Omega-3 fatty acids and fish oil

What public sources say about the safety of omega-3 fatty acids and fish oil: FDA adverse-event reports, NIH guidance on interactions with medicines, and the registered trials that test it.

⚠️
Research information, not medical advice. Supplements can interact with prescription medicines and affect conditions. Check with a pharmacist or your own clinician before starting or stopping one. Nothing here is a dose recommendation.

Interactions and safety, in NIH's words

Omega-3 dietary supplements, such as fish oil, have the potential to interact with medications. One example is provided below. People taking these and other medications on a regular basis should discuss possible interactions with their health care providers.

Fish oil can have antiplatelet effects at high doses, although it appears to be less potent than aspirin [197,198]. Fish oil might prolong clotting times, as indicated by an elevated international normalized ratio (INR), when it is taken with warfarin [199], but most research indicates that doses of 3–6 g/day fish oil do not significantly affect the anticoagulant status of patients taking warfarin [200]. The authors of a 2014 review concluded that omega-3s do not affect the risk of clinically significant bleeding [201], and the FDA-approved package inserts for omega-3 pharmaceuticals state that studies with omega-3s have not produced "clinically significant bleeding episodes" [202]. However, these package inserts also state that patients taking these products with anticoagulants should be monitored periodically for changes in INR.

Medicines covered in that section: Warfarin (Coumadin) and similar anticoagulants.

Quoted from the “Interactions with Medications” section: NIH Office of Dietary Supplements, health-professional fact sheet, retrieved 2026-11-16. Read the full page for the complete list and references.

FDA adverse-event reports (CAERS)

Reports are not rates. CAERS counts voluntary reports to the FDA from consumers, clinicians and companies. A report means someone linked a health problem to a product, not that the product caused it. There is no denominator: how many people took the product is unknown, so these numbers cannot show how common a problem is, and they cannot be compared between products. Popular products attract more reports.
921reports naming it in a suspect product
756where the product is named for it alone
2004–2026years covered, single-ingredient reports

Matching rule: reports in the dietary-supplement category where a product marked "suspect" has a brand name containing “FISH OIL”, “OMEGA-3”, “OMEGA 3”. Products that contain it without naming it are missed. Reports where it was only taken alongside the suspect product are not counted.

Combination products: 165 of the reports involve only products whose name lists another ingredient, such as calcium or a multivitamin. Their reactions may come from that other ingredient or from the tablet itself, so the reactions below count only the 756 reports where a product is named for omega-3 fatty acids and fish oil alone. This split is made from product names and can misfile some products. Most-reported products: Fish Oil (34); Naturemade Fish Oil (17); Krill Omega-3 Super Formula (15); Nature Made Fish Oil (14); Naturemade Fish Oil 1200 Mg (13); Naturemade Full Strength Mini Omega 3 (12).

Most reported reactions, single-ingredient reports
Most reported reactions (single-ingredient products)Reports
Dyspnoea111
Choking97
Diarrhoea81
Nausea65
Vomiting64
Foreign body54
Hypersensitivity50
Dizziness50
Blood pressure increased36
Headache34
Abdominal pain upper34
Pain33

Outcomes recorded in these reports (a report can have several): Other Serious or Important Medical Event (530), Hospitalization (174), Visited a Health Care Provider (158), Visited Emergency Room (119), Other Serious Outcome (100), Life Threatening (87), Required Intervention (35), Other Outcome (31).

Source: openFDA food and supplement adverse events (CAERS), retrieved 2026-11-16.

Registered trials

188 trials in the non-drug evidence map test this class of supplement. Trials with posted results are listed first; each shows the condition it was registered for. A trial testing it in one condition says nothing about another.

All supplement safety pages Non-drug evidence map